A detailed history of Jump Financial, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 189,955 shares of AUPH stock, worth $1.58 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
189,955
Holding current value
$1.58 Million
% of portfolio
0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.32 - $7.33 $1.01 Million - $1.39 Million
189,955 New
189,955 $1.39 Million
Q3 2023

Oct 21, 2024

SELL
$7.77 - $12.27 $55,695 - $87,951
-7,168 Reduced 29.53%
17,109 $132,000
Q3 2023

Nov 07, 2023

SELL
$7.77 - $12.27 $55,695 - $87,951
-7,168 Reduced 29.53%
17,109 $132,000
Q2 2023

Oct 21, 2024

SELL
$8.96 - $11.69 $81,329 - $106,110
-9,077 Reduced 27.21%
24,277 $235,000
Q2 2023

Aug 07, 2023

SELL
$8.96 - $11.69 $81,329 - $106,110
-9,077 Reduced 27.21%
24,277 $235,000
Q1 2023

Oct 21, 2024

BUY
$5.94 - $11.27 $198,122 - $375,899
33,354 New
33,354 $365,000
Q1 2023

May 03, 2023

BUY
$5.94 - $11.27 $198,122 - $375,899
33,354 New
33,354 $365,000
Q2 2022

Aug 09, 2022

BUY
$8.95 - $12.8 $101,609 - $145,318
11,353 Added 9.27%
133,853 $1.35 Million
Q1 2022

May 12, 2022

BUY
$10.05 - $22.48 $1.23 Million - $2.75 Million
122,500 New
122,500 $1.52 Million
Q3 2021

Nov 12, 2021

SELL
$10.93 - $23.55 $488,571 - $1.05 Million
-44,700 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$10.0 - $14.52 $447,000 - $649,044
44,700 New
44,700 $579,000
Q4 2020

Feb 12, 2021

SELL
$12.94 - $16.05 $446,430 - $553,725
-34,500 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$13.19 - $16.66 $455,055 - $574,770
34,500 New
34,500 $508,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.18B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.